- Home
- LITE vs OLMA Comparison
LITE vs OLMA Comparison
Compare LITE & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LITE | OLMA |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.0B | 2.6B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | LITE | OLMA |
|---|---|---|
| Price | $369.36 | $25.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 6 |
| Target Price | ★ $198.50 | $40.50 |
| AVG Volume (30 Days) | ★ 3.4M | 2.6M |
| Earning Date | 02-05-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.56 | N/A |
| Revenue | ★ $1,841,900,000.00 | N/A |
| Revenue This Year | $61.58 | N/A |
| Revenue Next Year | $31.87 | N/A |
| P/E Ratio | $236.62 | ★ N/A |
| Revenue Growth | ★ 33.62 | N/A |
| 52 Week Low | $45.65 | $2.86 |
| 52 Week High | $401.60 | $36.26 |
Technical Indicators
Market Signals| Indicator | LITE | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 59.63 | 48.26 |
| Support Level | $364.02 | $25.85 |
| Resistance Level | $401.60 | $36.26 |
| Average True Range (ATR) | 20.61 | 2.37 |
| MACD | -2.49 | -1.34 |
| Stochastic Oscillator | 63.99 | 4.26 |
Price Performance
Historical ComparisonAbout LITE Lumentum Holdings Inc.
Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.